Bioquell PLC (LSE:BQE) - Share price - Overview

Stock Report

Bioquell PLC BQE

Last Price
GBX129.00

Day Change
0.00|0.00%

As of 22/02/2017
14:39:20 GMT | GBX
Minimum 15 Minutes Delay.

Last Close129.00p
Day Range128.18 - 130.48
Mkt Cap28.39Mil
52-Wk Range119.50 - 178.00
Yield %2.56
ISINGB0004992003
Volume2,726
P/E57.18
P/S2.05
P/CF10.32

Share Price

Total Returns 21/02/2017

 Chg (%)  
More ...
Bioquell PLC-2.46 
FTSE 100 TR GBP1.47
 
Financials
201320142015
More ...
Income Statement
Turnover44.6427.2726.88
Operating Profit2.90-4.680.55
Net Profit3.05-3.780.64
Reported EPS7.20-8.901.50
Balance Sheet
Current Assets16.1917.9956.55
Non Current Assets28.9724.1514.31
Total Assets45.1642.1370.86
Current Liabilities7.757.654.59
Total Liabilities11.9011.085.94
Total Equity33.2631.0664.92
Cash Flow
Operating Cash Flow7.483.885.25
Net Change in Cash0.57-0.7144.72
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20161.393.7264.7034.720.541.801.40
20171.866.5275.4319.790.262.501.94
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/06/2016SaleMr. Christopher Mills200.006,305,00012,610,000.00
21/06/2016SaleMr. Simon Constantine200.00235,000470,000.00
21/06/2016SaleNicholas Adams200.00513,6971,027,394.00
21/06/2016SaleMr. Michael Roller200.009,62219,244.00

Company Profile

Bioquell PLC is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defence industries.

Sector

Medical Devices

Market Position

1269 of 1851 Companies

Index

FTSE Fledgling

Outlook

(19/01/2017) "We estimate that revenues for the year ended 31 December, 2016 will be broadly in line with market expectations"

Next Event 07/03/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)19.7917.0216.08
Div Yld (E)1.941.874.06
PEG (E)0.260.611.29
ROCE1.7930.82-29.87
Op Mrgn3.26-12.99-30.86
EPS Grwth75.4332.8737.62
Dividends
PreviousLatest
More ...
Record Date06/06/1405/06/15
Ex-Div04/06/1404/06/15
Paid02/07/1402/07/15
Amnt3.303.30

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Ian Johnson
Chief ExecutiveNicholas Adams
Group Finance DirectorMr. Michael Roller
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.